Aortography and peripheral angiography
J9 · Effective Oct 31, 2016
169 active Medicare policies list C72.0, and 13 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
Showing 100 of 169
J9 · Effective Oct 31, 2016
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6
J6 · Effective Jul 15, 2026
13 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of C72.0 |
|---|---|---|
| Back Pain - Invasive Procedures | Mar 13, 2024 | Covered |
| Bevacizumab for Non-Ocular Indications | Feb 20, 2024 | Covered |
| Brachytherapy | Jun 6, 2023 | Covered |
| Cerebral Perfusion Studies | Sep 14, 2023 | Covered |
| In Vivo Analysis of Gastro-Intestinal and Urothelial Lesions | Oct 17, 2023 | Covered |
| Intraoperative Neurophysiological Monitoring | Oct 26, 2023 | Covered |
JK
JK · Effective Jul 15, 2026
JJ · Effective Jul 24, 2022
JM · Effective Jul 24, 2022
J15 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Apr 1, 2019
JK · Effective Apr 1, 2019
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
JJ · Effective May 6, 2019
JM · Effective May 6, 2019
JE · Effective Aug 8, 2022
JF · Effective Aug 8, 2022
JJ · Effective Jul 3, 2022
JM · Effective Jul 3, 2022
J5 · Effective Jul 3, 2022
J8 · Effective Jul 3, 2022
J15 · Effective Dec 26, 2021
JE · Effective Jan 2, 2022
JF · Effective Jan 2, 2022
JJ · Effective Dec 26, 2021
JM · Effective Dec 26, 2021
J5 · Effective Dec 26, 2021
J8 · Effective Dec 26, 2021
J15 · Effective Feb 10, 2020
JE · Effective May 17, 2020
JF · Effective May 17, 2020
JJ · Effective Feb 10, 2020
JM · Effective Feb 10, 2020
J5 · Effective Feb 9, 2020
J8 · Effective Feb 9, 2020
J15 · Effective Jul 27, 2020
JE · Effective Dec 26, 2022
JF · Effective Dec 26, 2022
JJ · Effective Feb 3, 2020
JM · Effective Feb 3, 2020
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JE · Effective Jun 1, 2016
JF · Effective Jun 1, 2016
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective May 1, 2017
JK · Effective May 1, 2017
J9 · Effective Oct 1, 2015
J15 · Effective Oct 24, 2016
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Dec 3, 2023
JM · Effective Dec 3, 2023
JJ · Effective Nov 12, 2023
JM · Effective Nov 12, 2023
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
| Plerixafor | Jan 9, 2024 | Covered |
|---|
| Proton Beam, Neutron Beam, and Carbon Ion Radiotherapy | Oct 3, 2023 | Covered |
|---|
| Ribavirin for Inhalation Use | Mar 31, 2023 | Covered |
|---|
| Ziconotide (Prialt) | Sep 21, 2023 | Covered |
|---|
| Policy | Effective | Status of C72.0 |
|---|---|---|
| Electrodiagnostic Testing (EMG/NCV) | Sep 15, 2026 | Covered |
| Spinal Ultrasound | Sep 15, 2026 | Covered |
| Policy | Effective | Status of C72.0 |
|---|---|---|
| Urodynamic Testing (CP.MP.98) | Not recorded | Covered |